This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Apr 24:348:g2779.

doi: 10.1136/bmj.g2779.

The safety of incretin based drugs

Victor M Montori¹

Affiliations

PMID: 24764568
DOI: 10.1136/bmj.g2779

Editorial

The safety of incretin based drugs

Victor M Montori. BMJ. 2014.

. 2014 Apr 24:348:g2779.

doi: 10.1136/bmj.g2779.

Author

Victor M Montori¹

Affiliation

¹ Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA.

PMID: 24764568
DOI: 10.1136/bmj.g2779

No abstract available

PubMed Disclaimer

Comment on

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies.
Li L, Shen J, Bala MM, Busse JW, Ebrahim S, Vandvik PO, Rios LP, Malaga G, Wong E, Sohani Z, Guyatt GH, Sun X. Li L, et al. BMJ. 2014 Apr 15;348:g2366. doi: 10.1136/bmj.g2366. BMJ. 2014. PMID: 24736555 Free PMC article.
Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study.
Faillie JL, Azoulay L, Patenaude V, Hillaire-Buys D, Suissa S. Faillie JL, et al. BMJ. 2014 Apr 24;348:g2780. doi: 10.1136/bmj.g2780. BMJ. 2014. PMID: 24764569 Free PMC article.

Similar articles

Q: Do incretin drugs for type 2 diabetes increase the risk of acute pancreatitis?
Olansky L. Olansky L. Cleve Clin J Med. 2010 Aug;77(8):503-5. doi: 10.3949/ccjm.77a.09167. Cleve Clin J Med. 2010. PMID: 20682512 No abstract available.
ACP Journal Club. Incretin use was not associated with increased risk for acute pancreatitis.
Schectman J. Schectman J. Ann Intern Med. 2015 Jun 16;162(12):JC12. doi: 10.7326/ACPJC-2015-162-12-012. Ann Intern Med. 2015. PMID: 26075777 No abstract available.
Comment on Thomsen et al. Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study. Diabetes Care 2015;38:1089-1098.
Smits MM, Muskiet MH, Tonneijck L, van Raalte DH. Smits MM, et al. Diabetes Care. 2015 Jul;38(7):e106-7. doi: 10.2337/dc15-0367. Diabetes Care. 2015. PMID: 26106231 No abstract available.
Incretin therapy and its effect on body weight in patients with diabetes.
Lind M. Lind M. Prim Care Diabetes. 2012 Oct;6(3):187-91. doi: 10.1016/j.pcd.2012.04.006. Epub 2012 May 19. Prim Care Diabetes. 2012. PMID: 22613745 Review.
Using real-world data to evaluate the association of incretin-based therapies with risk of acute pancreatitis: a meta-analysis of 1,324,515 patients from observational studies.
Wang T, Wang F, Gou Z, Tang H, Li C, Shi L, Zhai S. Wang T, et al. Diabetes Obes Metab. 2015 Jan;17(1):32-41. doi: 10.1111/dom.12386. Epub 2014 Oct 6. Diabetes Obes Metab. 2015. PMID: 25200423

See all similar articles

Cited by

A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide.
Gurung T, Shyangdan DS, O'Hare JP, Waugh N. Gurung T, et al. Diabetes Metab Syndr Obes. 2015 Aug 10;8:363-86. doi: 10.2147/DMSO.S34418. eCollection 2015. Diabetes Metab Syndr Obes. 2015. PMID: 26316788 Free PMC article. Review.
Drug therapies in type 2 diabetes: an era of personalised medicine.
Chowdhury TA, Grant P. Chowdhury TA, et al. Clin Med (Lond). 2016 Oct;16(5):441-447. doi: 10.7861/clinmedicine.16-5-441. Clin Med (Lond). 2016. PMID: 27697806 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information